Latest News - FDA Approval/Clearance
Tuesday, April 30, 2019 | FDA Approval/Clearance, Personnel/Company News, PracticalDermatology.com, Galderma
Galderma's Dysport Celebrates 10 Years Since FDA Approval
Galderma Laboratories’ Dysport (abobotulinumtoxinA) is ringing in its 10th birthday. To celebrate this milestone, Galderma is offering double points for Dysport aesthetic treatments registere…
Read the full story
Tuesday, February 12, 2019 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates, American Academy of Dermatology, American Society for Laser Medicine and Surgery
Laseroptek’s PicoLO Scores FDA 510(k) Marketing Clearance
Laseroptek’s PicoLO picosecond Nd:YAG laser is now U.S. Food and Drug Administration-cleared for marketing in dermatology and general and plastic surgery. According to the company, PicoLO gen…
Read the full story
Tuesday, February 12, 2019 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates
FDA Clears Lutronic Genius Platform for RF Microneedling
Lutronic has received FDA clearance of the Lutronic Genius™ platform for radiofrequency microneedling. The company says the device transmits energy more precisely into the skin. …
Read the full story
Saturday, February 02, 2019 | FDA Approval/Clearance, Personnel/Company News, PracticalDermatology.com, Evolus
Evolus: Jeuveau FDA Cleared for Aesthetic Injection
The FDA has approved Jeuveau™ (prabotulinumtoxinA-xvfs), the lead product from Evolus, Inc., for the temporary improvement in the appearance of moderate to severe glabellar lines associated with…
Read the full storyWednesday, December 19, 2018 | FDA Approval/Clearance, Product Launches and Updates, Allergan
Allergan Withdraws Sales of Textured Breast Implants, Tissue Expanders in Europe
Allergan is suspending sales of textured breast implants and tissue expanders and is withdrawing any remaining supply in European markets. The withdrawal decision follows a compulsory recall reques…
Read the full story
Thursday, December 13, 2018 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates, Cynosure
Hologic’s Cynosure Division Rolls Out TempSure Surgical RF Technology in North America
Hologic, Inc.’s Cynosure division is launching the U.S. Food and Drug Administration (FDA)-cleared TempSure Surgical RF technology in North America. This is a new offer…
Read the full story
Monday, November 05, 2018 | FDA Approval/Clearance, PracticalDermatology.com, Research and Publications, Galderma
FDA Green Light’s Galderma’s Restylane Lyft for Midface Injection Via Cannula
The U.S. Food and Drug Administration (FDA) has approved the use of Galderma’s Restylane Lyft with a small, blunt-tip cannula for cheek augmentation and the correction of age-related m…
Read the full story
Tuesday, September 18, 2018 | FDA Approval/Clearance, Phase 3/4 Trials, PracticalDermatology.com, PracticalDermatology.com
New for EBD-Based Acne Care: Sebacia Microparticles Cleared
Sebacia Microparticles are now FDA-cleared for use in the treatment of acne. The clearance comes on the heels of a pivotal study demonstrating the clinical safety and efficacy of the micoparticles. Se…
Read the full story
Wednesday, September 05, 2018 | FDA Approval/Clearance, PracticalDermatology.com, Almirall, ThermiAesthetics
Thermi Debuts Arvati Platform
Thermi, an Almirall company, is launching Arvati, a next-generation 510K US Food and Drug Administration-cleared, true temperature-controlled radiofrequency platform that powers a range of Thermi proc…
Read the full storyTuesday, July 31, 2018 | FDA Approval/Clearance, PracticalDermatology.com
FDA: Energy-Based Vaginal Rejuvenation May Cause Burns, Scarring
The FDA is cracking down on the use energy-based devices to perform vaginal 'rejuvenation.' The use of such devices to perform vaginal "rejuvenation," cosmetic vaginal procedures,…
Read the full story
Monday, July 16, 2018 | FDA Approval/Clearance, Personnel/Company News, PracticalDermatology.com, Product Launches and Updates
Candela Launches Vbeam Prima
Recently FDA-cleared, the Vbeam Prima from Candela offers two wavelengths to effectively treat a broad range of skin conditions including rosacea, spider veins, wrinkles, acne and …
Read the full story
Friday, June 29, 2018 | FDA Approval/Clearance
FDA Approves Dermira's Qbrexza Cloth for Hyperhidrosis
A new hyperhydrosis treatment is now FDA approved. The FDA has approved Qbrexza™ (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of primary axillary hyperhidrosis …
Read the full storyWednesday, May 30, 2018 | FDA Approval/Clearance, Personnel/Company News, PracticalDermatology.com
Revance Vet Tapped as New Evolus CFO
Lauren Silvernail is the new Chief Financial Officer and Executive Vice President, Corporate Development at Evolus, Inc. Silvernail joins Evolus from Revance Therapeutics where she most recently se…
Read the full storyMonday, May 21, 2018 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates
Restylane Lyft Now FDA-Approved for Hands
The US Food and Drug Administration has approved Restylane Lyft for use on the dorsal hands of people older then 21, making it the first hyaluronic acid (HA) injectable gel approved for this…
Read the full storyWednesday, May 16, 2018 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates
FDA Says No to Evolus' Botox Rival
The U.S Food and Drug Administration did not approve DWP-450, Evolus Inc's rival product to Allergan Plc's Botox, due to chemistry and manufacturing issues. As a result, the company pushed …
Read the full story